yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38235601-217E7B75-9836-474C-934C-7DCCF345CF9D
Q38235601-217E7B75-9836-474C-934C-7DCCF345CF9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38235601-217E7B75-9836-474C-934C-7DCCF345CF9D
Nemonoxacin: first global approval.
P2860
Q38235601-217E7B75-9836-474C-934C-7DCCF345CF9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38235601-217E7B75-9836-474C-934C-7DCCF345CF9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a790b2372d61cc381fa2fe7906351fb3dd6387a
P2860
Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers.